Effect of Branch Chain Amino Acid therapy on muscle mass in children with chronic liver disease
Not Applicable
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2021/11/038012
- Lead Sponsor
- ILBS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children 6 mo â?? 12 y with cirrhosis and sarcopenia defined as MAMA <2 SD for age
Exclusion Criteria
•Non-cirrhotic Portal hypertension
•Suspected/proven malignancy
•Already on BCAA therapy in last 1 month
•Tyrosinemia
•Chronic kidney disease or non-resolving AKI
•Potential liver transplant within 1 month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method